Apex Science & Engineering Corp.

TWSE:3052 Voorraadrapport

Marktkapitalisatie: NT$2.5b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Apex Science & Engineering Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Apex Science & Engineering heeft een totaal eigen vermogen van NT$3.4B en een totale schuld van NT$3.9B, wat de schuld-eigenvermogensverhouding op 115.5% brengt. De totale activa en totale passiva bedragen respectievelijk NT$8.2B en NT$4.8B. De EBIT Apex Science & Engineering is NT$185.5M waardoor de rentedekking -7.1 is. Het heeft contanten en kortetermijnbeleggingen van NT$533.9M.

Belangrijke informatie

115.5%

Verhouding schuld/eigen vermogen

NT$3.90b

Schuld

Rente dekkingsratio-7.1x
ContantNT$533.90m
AandelenNT$3.38b
Totaal verplichtingenNT$4.80b
Totaal activaNT$8.18b

Recente financiële gezondheidsupdates

Recent updates

Apex Science & Engineering (TWSE:3052) Will Pay A Dividend Of NT$0.40

Aug 10
Apex Science & Engineering (TWSE:3052) Will Pay A Dividend Of NT$0.40

The Return Trends At Apex Science & Engineering (TWSE:3052) Look Promising

Aug 07
The Return Trends At Apex Science & Engineering (TWSE:3052) Look Promising

Apex Science & Engineering's (TWSE:3052) Conservative Accounting Might Explain Soft Earnings

Mar 22
Apex Science & Engineering's (TWSE:3052) Conservative Accounting Might Explain Soft Earnings

Investors Aren't Buying Apex Science & Engineering Corp.'s (TPE:3052) Earnings

Apr 07
Investors Aren't Buying Apex Science & Engineering Corp.'s (TPE:3052) Earnings

Apex Science & Engineering Corp.'s (TPE:3052) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Mar 19
Apex Science & Engineering Corp.'s (TPE:3052) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

What Can The Trends At Apex Science & Engineering (TPE:3052) Tell Us About Their Returns?

Feb 26
What Can The Trends At Apex Science & Engineering (TPE:3052) Tell Us About Their Returns?

Is It Worth Buying Apex Science & Engineering Corp. (TPE:3052) For Its 4.1% Dividend Yield?

Feb 05
Is It Worth Buying Apex Science & Engineering Corp. (TPE:3052) For Its 4.1% Dividend Yield?

Apex Science & Engineering (TPE:3052) Seems To Use Debt Quite Sensibly

Jan 19
Apex Science & Engineering (TPE:3052) Seems To Use Debt Quite Sensibly

Did You Miss Apex Science & Engineering's (TPE:3052) 53% Share Price Gain?

Jan 01
Did You Miss Apex Science & Engineering's (TPE:3052) 53% Share Price Gain?

Is Apex Science & Engineering Corp.'s (TPE:3052) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Dec 14
Is Apex Science & Engineering Corp.'s (TPE:3052) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Should You Use Apex Science & Engineering's (TPE:3052) Statutory Earnings To Analyse It?

Nov 26
Should You Use Apex Science & Engineering's (TPE:3052) Statutory Earnings To Analyse It?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( NT$7.5B ) 3052 } overtreffen de korte termijn passiva ( NT$4.2B ).

Langlopende schulden: De kortetermijnactiva 3052 ( NT$7.5B ) overtreffen de langetermijnschulden ( NT$578.8M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 99.7% ) 3052 wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 3052 is de afgelopen 5 jaar gedaald van 207.9% naar 115.5%.

Schuldendekking: De schuld van 3052 wordt goed gedekt door de operationele kasstroom ( 54% ).

Rentedekking: 3052 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.


Balans


Ontdek gezonde bedrijven